Quarterly report pursuant to Section 13 or 15(d)

License, Clinical Trial and Sponsored Research Agreements (Tables)

v3.8.0.1
License, Clinical Trial and Sponsored Research Agreements (Tables)
 3 Months Ended
Mar. 31, 2018
License Agreement Disclosure [Abstract]  
Research and Development Arrangement, Contract to Perform for Others [Table Text Block]
For the three months ended March 31, 2018 and 2017, the Company recorded the following expense in research and development for licenses acquired:
 
 
 
For the three months ended March 31,
 
($ in thousands)
 
2018
 
2017
 
City of Hope
 
 
 
 
 
 
 
Manufacturing
 
$
75
 
$
-
 
IL13Ra2
 
 
-
 
 
250
 
IV/ICV
 
 
-
 
 
125
 
UCLA
 
 
-
 
 
200
 
Total
 
$
75
 
$
575
 
 
For the three months ended March 31, 2018 and 2017, the Company recorded the following expense in research and development for sponsored research and clinical trial agreements:
 
 
 
For the three months ended March 31,
 
 
 
2018
 
2017
 
($ in thousands)
 
 
 
 
 
 
 
City of Hope
 
$
500
 
$
500
 
City of Hope - CD123
 
 
150
 
 
20
 
City of Hope - IL13Ra2
 
 
360
 
 
9
 
City of Hope - Manufacturing
 
 
114
 
 
-
 
Fred Hutch - CD20
 
 
266
 
 
-
 
Total
 
$
1,390
 
$
529